BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Biocytogen Launches “Nano 100 Project” to Develop Fully Human Nanobody Therapeutics for Over 100 Targets

Compared to traditional antibodies, nanobodies have smaller molecular weights and improved tissue penetration ability, which make them effective at infiltr...

February 22, 2023 | News

Chrysalis Advisory and TriNetX collaborate to aid research teams in Australia and New Zealand

The goal of the collaboration is to extend the availability of consulting services to healthcare organizations in the region who are in need of assistance ...

February 22, 2023 | News

Biomimicry in Biotech: Researchers Look to Nature for Solutions to Human Health Problems

By studying and replicating natural systems, scientists are uncovering new avenues for drug development, medical device design, and even disease prevention...

February 17, 2023 | Opinion

GNOMIX: Australian Study Uses MGI's DNBSEQ™ Platforms to Make Genomics Applications Accessible to All

Currently the clinical genomics landscape in Australia is strongly influenced by a couple of major players heavily driven by profit to provide a ...

February 17, 2023 | News

Gilead to present data at APASL 2023 on effective models for monitoring and treating hepatitis C and efficacy of antiviral treatments for HIV-1 and HBV-coinfected adults

-- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with ...

February 15, 2023 | News

Scientists Develop AI-based Method to Predict Rna Modifications

A team of researchers from the Agency for Science, Technology and Research (A*STAR) and the National University of Singapore (NUS) has developed a&nb...

February 09, 2023 | News

EYLEA now approved to treat five retinal conditions caused by ocular angiogenesis

ROP is a leading cause of childhood blindness worldwide Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug...

February 09, 2023 | News

Nectin Therapeutics to Collaborate with Merck on a Clinical Trial of Anti-PVR Antibody NTX1088

Nectin Therapeutics Ltd. (Nectin), a biotechnology company developing novel targeted immunotherapies that address resistance to approved immune oncology tr...

February 08, 2023 | News

Psychedelic-Assisted Therapies Allowed in Australia Through Special Access Scheme

As the funder and sponsor of the most advanced research of a psychedelic-assisted therapy, MAPS is encouraged to see a fourth nation provide access to some...

February 06, 2023 | News

GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer

Combined with other clinical risk factors the test provides a comprehensive risk assessment in a simple saliva test. Highlights: New test integ...

February 03, 2023 | News

TransCure bioServices offers BioVolume 3D imaging for insightful preclinical oncology research

TransCure bioServices adds BioVolume 3D imaging to its service offerings, enabling them to deliver even higher quality tumor growth results to customers. W...

February 02, 2023 | News

Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short

The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcom...

February 01, 2023 | News

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

First Generic of Abraxane in Korea, World 4th Commercial Scale-Up Global tech-transfer expected to US, Japan, and Europe Through this contr...

January 26, 2023 | News

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...

January 23, 2023 | News

Stay Connected